| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.031 | 0.3 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.056 | 0.3 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.054 | 0.3 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.031 | 0.3 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |